IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Copernicus Capital Management, LLC

Q1 2020 Holdings

Filed 2020-05-14 | 14 holdings | $17.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$8.7M103,17950.5%
Biogen Inc(BIIB)COM09062X103$5.7M18,00033.0%
Centene Corp del(CNC)COM15135B101$2.8M47,00016.2%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$12.5K52,4530.1%
Bristol-Myers Squibb Co(BMY)COM110122108$9.9K176,9970.1%
Cigna Corp New(CI)COM125523100$9.7K54,7480.1%
CVS Health Corp(CVS)COM126650100$7.7K130,0000.0%
Mckesson Corp(MCK)COM58155Q103$6.9K51,0000.0%
Thermo Fisher Scientific Inc(TMO)COM883556102$5.4K18,8960.0%
Fate Therapeutics Inc(FATE)COM31189P102$3.6K160,9590.0%
Zoetis Inc(ZTS)CL A98978V103$3.5K30,1250.0%
Tandem Diabetes Care Inc(TNDM)COM NEW875372203$2.7K42,6850.0%
Arena Pharmaceuticals Inc(ARNAEUR)COM NEW040047607$1.9K45,0000.0%
Shockwave MED Inc(SWAVUSD)COM82489T104$1.7K50,0000.0%